Hugel launched its new product, ‘BYRYZN Skinbooster Exummit,’ on the 11th.


Hugel's 'Bylize Skinbooster Exermit' <br>[Photo by Hugel]

Hugel's 'Bylize Skinbooster Exermit'
[Photo by Hugel]

View original image

Exummit is the second lineup of Hugel's brand 'BYRYZN,' released about 20 months after ‘BYRYZN Skinbooster HA.’ The product name Exummit signifies the company's commitment to delivering the ‘Summit’ of skin beauty.


Unlike the injectable skinbooster HA, which contains a high concentration of hyaluronic acid (HA), Exummit is a skincare type applied topically to the skin. The company explained that it contains adipose-derived stem cell conditioned media (ADSC-CM), known as a 4th generation skinbooster, along with over 150 growth factor proteins, niacinamide, and adenosine, which help improve skin wrinkles, hydration, and whitening.


To extract the key ingredients with high purity and efficiency without physical or chemical damage, various patented technologies such as ExoPlant and ExoTraction were applied. The entire production process, including donor selection, culturing, and quality control of stem cells, was conducted in accordance with the safety standards for conditioned media set by the Ministry of Food and Drug Safety.


Exummit’s main ingredients’ effects and functionalities have also been proven through SCI-level papers. Adipose-derived stem cell conditioned media (ADSC-CM) was found to aid skin regeneration, improve wrinkles and skin barrier, and increase collagen.


Exummit was launched in a high dose (270 mg) to enhance satisfaction among medical professionals and consumers. It can also be used in combination with various laser devices and absorption/soothing care equipment.



A Hugel representative said, “As interest and demand for beauty and plastic surgery procedures increase, we launched this new product to provide a wider range of product choices. We will continue to strengthen our product portfolio so that BYRYZN can establish itself as a total skin solution brand.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing